# US Digital Diabetes Management Market > US Digital Diabetes Management Market Research Report: Size, Share, Trend Analysis By Technology (Mobile Applications, Wearable Devices, Remote Monitoring Solutions, Telehealth Services), By Product Type (Blood Glucose Monitors, Insulin Delivery Devices, Continuous Glucose Monitoring Systems, Diabetes Management Software), By End Users (Patients, Healthcare Professionals, Pharmacies, Diabetes Care Centers) and By Functionality (Data Management, Patient Engagement, Clinical Decision Support, Remote Patient Monitoring) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 12.58% - **2024:** $ 950 Million - **2025:** $ 1,069.51 Million - **2035:** $ 3,499 Million - **Key Players:** Abbott (US), Medtronic (US), Roche (CH), Dexcom (US), Ascensia Diabetes Care (DE), Insulet Corporation (US), Tandem Diabetes Care (US), Glooko (US) **Report ID:** MRFR/HC/18078-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-digital-diabetes-management-market-19625 --- ## Market Summary ## **US Digital Diabetes Management Market Overview** As per MRFR analysis, the US Digital Diabetes Management Market Size was estimated at 1.87 (USD Billion) in 2023. The US Digital Diabetes Management Market Industry is expected to grow from 2.16 (USD Billion) in 2024 to 12.36 (USD Billion) by 2035. The US Digital Diabetes Management Market CAGR (growth rate) is expected to be around 17.199% during the forecast period (2025 - 2035). ### **Key US Digital Diabetes Management Market Trends Highlighted** The US Digital Diabetes Management Market is experiencing significant growth driven by increasing diabetes prevalence and demand for enhanced patient engagement tools. The rising incidence of Type 1 and Type 2 diabetes, fueled by lifestyle changes and an aging population, has led to a greater need for innovative management solutions. Moreover, a shift towards digital health technologies is evident as healthcare providers and patients seek more effective ways to monitor and manage diabetes. The integration of telehealth services into diabetes care is gaining traction, allowing patients to consult with healthcare professionals remotely, which has become particularly relevant during the pandemic. Opportunities to be explored in the market include the development of tailored applications that cater to specific demographics, such as elderly patients or children. There is also a growing trend towards personalization in diabetes management solutions, where digital platforms can analyze user data to provide customized insights and recommendations. The potential for partnerships between technology companies and healthcare institutions is substantial, providing access to larger patient populations and advancing the use of artificial intelligence in managing diabetes. Trends in recent times show a strong focus on data security and patient privacy within digital platforms as regulatory compliance becomes increasingly paramount. Additionally, the rise of wearable devices equipped with continuous glucose monitoring capabilities points towards a more proactive approach in diabetes management. This not only empowers patients to take charge of their health but also provides healthcare professionals with real-time data to adjust treatment plans effectively. Collectively, these trends and drivers are likely to shape the future of the US Digital Diabetes Management Market as stakeholders work to improve outcomes and enhance the quality of life for individuals living with diabetes. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Digital Diabetes Management Market Drivers** ### **Increasing Prevalence of Diabetes in the United States** The rising number of diabetes cases in the United States is a significant driver for the US [Digital Diabetes Management Market](../../../reports/digital-diabetes-management-market-7527) Industry. According to the Centers for Disease Control and Prevention (CDC), approximately 34.2 million people in the US had diabetes in 2020, which represents around 10.5% of the total population. This alarming rise, including a 2% increase over the past five years, is attributed to various factors, including obesity and an aging population. The CDC projects that by 2030, the number of individuals diagnosed with diabetes could grow to 54 million. Major organizations, such as the American Diabetes Association, are actively working towards awareness and management of diabetes, thereby boosting demand for digital diabetes management solutions. These solutions help in monitoring blood glucose levels, providing dietary recommendations, and allowing for remote consultations, contributing to the continuous growth of the US Digital Diabetes Management Market. ### **Technological Advancements in Digital Health Solutions** Rapid advancements in technology are another catalyst for growth within the US Digital Diabetes Management Market Industry. The integration of smart devices, mobile health applications, and data analytics into diabetes management has transformed patient care. For instance, wearable glucose monitoring devices deliver real-time data to patients and healthcare providers, ensuring immediate adjustments to treatment plans. According to the American Association of Diabetes Educators, 80% of patients with diabetes report that technology has enhanced their ability to manage the condition. Companies like Dexcom and Abbott are pioneering innovations in continuous glucose monitoring systems, making them more accessible and efficient for managing diabetes, which propels market expansion. ### **Increased Investment in Digital Health Startups** Another important factor driving the US Digital Diabetes Management Market is the increasing investment in digital health startups focusing on diabetes management. Reports indicate that venture capital investments in health tech, specifically aimed at diabetes management technologies, rose by over 35% between 2018 and 2022. This trend highlights a growing confidence in digital solutions to improve health outcomes. Organizations like Johnson & Johnson and Medtronic are actively investing in innovative solutions, fostering collaborations with startups to enhance their service offerings. This financial backing enables cutting-edge research and product development, thereby expanding market opportunities in the US. ## **US Digital Diabetes Management Market Segment Insights** ### **Digital Diabetes Management Market Technology Insights** The Technology segment of the US Digital Diabetes Management Market plays a crucial role in transforming diabetes care for millions of patients across the country. As the prevalence of diabetes continues to rise in the United States, innovative technology solutions are becoming increasingly important for disease management. Mobile applications have gained full traction among users, offering convenient interfaces for monitoring blood glucose levels, tracking insulin intake, and sharing data with healthcare providers. These applications not only enhance patient engagement but also empower individuals to take control of their health through personalized insights and reminders. Moreover, wearable devices have emerged as significant tools, enabling real-time tracking of various health metrics, including glucose levels, physical activity, and sleep patterns. The seamless integration of wearable technology into daily life enhances the ability to manage diabetes effectively, thereby minimizing complications associated with the disorder. Remote monitoring solutions have also become pivotal in diabetes management, as they facilitate continuous health tracking while reducing the need for frequent in-person visits to healthcare facilities. This is particularly beneficial in urban and rural areas where access to healthcare may be limited. By leveraging data collected from devices, healthcare providers can make more informed decisions about treatment and adjustments, ultimately leading to improved patient outcomes. Telehealth services are further enhancing the landscape of diabetes management; these services allow patients to consult healthcare professionals from the comfort of their homes, breaking barriers related to geographic location and enabling timely care. The demand for telehealth solutions has surged, especially in the wake of the COVID-19 pandemic, which highlighted the need for remote health services. Overall, the Technology segment within the US Digital Diabetes Management Market showcases a diverse range of solutions that cater to the unique needs of diabetic patients. As the market continues to evolve, integrating advancements in technology will likely lead to innovative products and services that improve health outcomes and quality of life for individuals living with diabetes. The ongoing development in artificial intelligence (AI) and machine learning is expected to further enhance these technologies, empowering patients with even more effective management tools. Coupled with strong support from healthcare policies promoting digital health, the Technology segment is poised for robust growth and will remain a cornerstone of diabetes care for years to come, ultimately contributing to substantial economic gains and healthier communities. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Digital Diabetes Management Market Product Type Insights** The US Digital Diabetes Management Market is experiencing significant growth, particularly within the Product Type segment, which consists of crucial categories including Blood Glucose Monitors, Insulin Delivery Devices, Continuous Glucose Monitoring Systems, and Diabetes Management Software. The importance of Blood Glucose Monitors is underscored by their capability to provide users with immediate feedback on glucose levels, aiding in timely decision-making for better health outcomes. Insulin Delivery Devices are essential as they help streamline insulin administration, making it more convenient for users to manage their diabetes effectively. Continuous Glucose Monitoring Systems are becoming increasingly popular due to their ability to provide real-time glucose readings, minimizing the risk of hypoglycemia or hyperglycemia, which is a notable concern in diabetes management. Meanwhile, Diabetes Management Software plays a critical role in personalizing treatment plans, helping users track their metrics and find patterns in their glucose levels. Collectively, these components of the US Digital Diabetes Management Market reflect a broader trend towards more integrated and patient-centric diabetes care, driven by technological advancements and a growing emphasis on preventive health measures. ### **Digital Diabetes Management Market End User Insights** The US Digital Diabetes Management Market is experiencing significant evolution within its End User segment, which includes Patients, Healthcare Professionals, Pharmacies, and Diabetes Care Centers. Patients increasingly rely on digital solutions for effective daily management of their condition, fostering better engagement and adherence to treatment regimens. Healthcare professionals utilize digital management tools to streamline monitoring and improve patient outcomes while enhancing communication with patients regarding their care. Pharmacies are adapting to the digital landscape by offering technology-driven services, which allows them to play a crucial role in managing diabetes through prescription and medication management. Furthermore, Diabetes Care Centers leverage digital platforms to provide comprehensive care, educating patients and coordinating treatment plans effectively. The increasing prevalence of diabetes in the US has catalyzed growth in these segments, as they strive to enhance patient care quality and accessibility. Coupled with advancements in technology and growing awareness of diabetes management, these factors collectively contribute to the ongoing growth and transformation of the digital diabetes management landscape. The focus on personalized solutions powered by data analytics and mobile applications exemplifies the market's potential to revolutionize diabetes care across various end user segments, ensuring better health outcomes for individuals living with diabetes. ### **Digital Diabetes Management Market Functionality Insights** The Functionality segment of the US Digital Diabetes Management Market plays a crucial role in providing comprehensive solutions for individuals living with diabetes. This segment encompasses various capabilities such as Data Management, Patient Engagement, Clinical Decision Support, and Remote Patient Monitoring, which collectively empower patients and healthcare providers. Data Management is essential for tracking glucose levels and ensuring accurate reporting, while Patient Engagement tools enhance communication between patients and providers, motivating adherence to treatment plans. Clinical Decision Support systems facilitate timely clinical interventions by identifying trends and suggesting adjustments to therapy, thus improving patient outcomes. Remote Patient Monitoring is increasingly significant, enabling continuous health tracking and timely alerts for patients, consequently supporting proactive diabetes management. The growth of this segment is largely driven by the rising prevalence of diabetes in the US and the increasing adoption of digital health technologies. Furthermore, with advancements in wearables and mobile applications, patients are more equipped than ever to manage their condition effectively. This segment is witnessing a shift towards personalization and tailored solutions, addressing the unique needs of individuals with diabetes, ultimately leading to improved health management and quality of life. ## **US Digital Diabetes Management Market Key Players and Competitive Insights** The US Digital Diabetes Management Market has been experiencing significant growth fueled by the increasing prevalence of diabetes, rising awareness among patients, and advancements in technology that facilitate better disease management. Digital solutions encompassing mobile applications, cloud platforms, and telehealth services have transformed diabetes care, enabling personalized management and remote monitoring. This burgeoning market is characterized by a diverse range of players, including technology companies, healthcare providers, and pharmaceutical firms, all vying for a competitive edge through innovative offerings, enhanced customer engagement, and strategic partnerships. As competition intensifies, companies are focusing on optimizing their product features, expanding service reach, and cultivating consumer trust to stand out in a rapidly evolving landscape. Glooko has established a solid foothold in the US Digital Diabetes Management Market by offering a comprehensive platform that integrates data from various blood glucose meters, continuous glucose monitors, and insulin pumps. The company's key strength lies in its ability to provide a user-friendly interface that allows patients and healthcare providers to easily analyze data and gain actionable insights for better diabetes management. Glooko's commitment to facilitating improved health outcomes through its data-driven approach has garnered it a loyal user base. Moreover, Glooko's strategic partnerships with healthcare organizations and payers have further enhanced its market presence and allowed it to tap into a larger network, making their digital solutions more accessible to those in need. Bigfoot Biomedical has made significant advancements in the US Digital Diabetes Management Market, particularly with its innovative automation solutions for insulin delivery. A standout feature of Bigfoot’s offerings is its adaptable technology designed for individual patient needs, which simplifies the management of diabetes through seamless integration with existing devices. The company has been active in establishing key partnerships to enhance its service offerings and bolster its market presence. By collaborating with stakeholders in the healthcare and technology sectors, Bigfoot Biomedical seeks to create an ecosystem that supports patients in navigating their diabetes management. The company also focuses on continuous improvement through research and development, ensuring its solutions remain at the forefront of the market. In addition, Bigfoot Biomedical has pursued strategic mergers and acquisitions aimed at enhancing its product portfolio and expanding its impact within the US diabetes management landscape. By concentrating on customer-centric solutions and innovative technologies, Bigfoot Biomedical looks to solidify its role as a leader in the digital management of diabetes. ### **Key Companies in the US Digital Diabetes Management Market Include** ## **US Digital Diabetes Management Market Industry Developments** In recent months, the US Digital Diabetes Management Market has witnessed notable advancements and developments. Companies such as Glooko, Dexcom, and Omada Health continue to innovate in digital health solutions, focusing on enhancing user engagement and diabetes management outcomes. Medtronic has been expanding its integrated diabetes management systems, improving patient accessibility and connectivity. Notably, in September 2023, Abbott Laboratories announced the launch of a new smart glucose monitoring device aimed at enhancing user experience and data sharing globally. Additionally, in August 2023, Livongo Health and WellDoc teamed up to enhance digital behavioral strategies for chronic condition management, signaling a strategic collaboration to broaden their service offerings. Furthermore, the market shows consistent growth trajectories, with companies such as Bigfoot Biomedical reporting significant increases in market valuations. This growth reflects a heightened demand for technology-driven diabetes solutions amid rising diabetes prevalence in the United States. Recent events within the past two years also include collaborations between Novo Nordisk and MySugr aimed at integrating data into personalized treatment plans, reflecting the sector's combined efforts toward improving patient outcomes through digital transformation in chronic disease management. ## **US Digital Diabetes Management Market Segmentation Insights** ### **Digital Diabetes Management Market Technology Outlook** ### **Digital Diabetes Management Market Product Type Outlook** ### **Digital Diabetes Management Market End User Outlook** ### **Digital Diabetes Management Market Functionality Outlook** ## Market Drivers ### Increasing Prevalence of Diabetes The rising incidence of diabetes in the US is a primary driver for the digital diabetes-management market. According to the Centers for Disease Control and Prevention (CDC), approximately 34.2 million Americans, or 10.5% of the population, have diabetes. This alarming statistic underscores the urgent need for effective management solutions. As the number of diagnosed cases continues to grow, the demand for digital tools that facilitate monitoring and management of diabetes is likely to increase. The digital diabetes-management market is expected to expand as healthcare providers and patients seek innovative solutions to improve health outcomes and reduce complications associated with diabetes. This trend suggests a robust market potential for digital health technologies that can assist in daily management and provide real-time data to both patients and healthcare professionals. ### Technological Advancements in Health Monitoring Technological innovations play a crucial role in shaping the digital diabetes-management market. The development of advanced health monitoring devices, such as continuous glucose monitors (CGMs) and insulin delivery systems, has transformed diabetes care. These devices enable patients to track their glucose levels in real-time, leading to more informed decision-making regarding their health. The integration of artificial intelligence (AI) and machine learning into these technologies further enhances their capabilities, allowing for personalized treatment plans. As these technologies become more accessible and affordable, the digital diabetes-management market is poised for growth. The increasing adoption of smart devices and applications that facilitate data sharing between patients and healthcare providers indicates a shift towards more proactive diabetes management. ### Growing Demand for Personalized Healthcare Solutions The digital diabetes-management market is significantly influenced by the increasing demand for personalized healthcare solutions. Patients are increasingly seeking tailored approaches to their diabetes management, which can be facilitated through digital platforms. These platforms often utilize data analytics to provide customized recommendations based on individual health metrics. The trend towards personalized medicine is supported by a growing body of evidence suggesting that individualized treatment plans can lead to better health outcomes. As healthcare systems in the US continue to evolve, the integration of personalized digital solutions is likely to become a standard practice. This shift not only enhances patient engagement but also fosters a more collaborative relationship between patients and healthcare providers, driving growth in the digital diabetes-management market. ### Rising Healthcare Costs and Focus on Cost-Effectiveness The escalating costs associated with diabetes care are a significant driver for the digital diabetes-management market. The American Diabetes Association estimates that the total cost of diagnosed diabetes in the US was $327 billion in 2017, a figure that has likely increased. As healthcare costs continue to rise, both patients and providers are seeking cost-effective solutions to manage diabetes. Digital tools that offer remote monitoring and telehealth services can reduce the need for frequent in-person visits, thereby lowering overall healthcare expenses. This focus on cost-effectiveness is likely to propel the adoption of digital diabetes-management solutions, as they provide a means to improve care while managing financial burdens. The market is expected to benefit from this trend as stakeholders prioritize solutions that deliver value without compromising quality. ### Increased Awareness and Education on Diabetes Management There is a growing awareness and education regarding diabetes management among the US population, which serves as a catalyst for the digital diabetes-management market. Public health campaigns and educational initiatives have significantly improved understanding of diabetes and its complications. As individuals become more informed about the importance of effective management, they are more likely to seek out digital solutions that can assist them in their daily lives. This heightened awareness is fostering a culture of proactive health management, where patients actively engage with digital tools to monitor their condition. Consequently, the digital diabetes-management market is likely to experience growth as more individuals recognize the benefits of utilizing technology in their diabetes care. ## Future Outlook The [Digital Diabetes Management Market](https://www.marketresearchfuture.com/reports/digital-diabetes-management-market-7527) is projected to grow at a 12.58% CAGR from 2025 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising demand for personalized healthcare solutions. **New opportunities:** - Development of AI-driven predictive analytics tools for patient management. Expansion of telehealth services tailored for diabetes care. Integration of wearable devices with real-time data sharing capabilities. By 2035, the market is expected to be robust, driven by innovation and increased consumer engagement. ## Segment Insights ### By Technology: Glucose Monitoring Devices (Largest) vs. Diabetes Management Software (Fastest-Growing) In the US digital diabetes-management market, the distribution of market share among segment values reveals a strong preference for Glucose Monitoring Devices, which command the largest share due to their critical role in daily diabetes management. Insulin Delivery Devices and Diabetes Management Software also hold significant positions, demonstrating the diverse needs of diabetes patients. Mobile Applications are capturing an increasing share as more users seek mobile solutions for health management. Growth trends within this segment are driven by technological advancements, including the integration of artificial intelligence in devices and software. The increasing prevalence of diabetes in the US is fostering demand for innovative solutions. Additionally, the rise of telehealth services is accelerating the adoption of digital diabetes management tools, particularly diabetes management software and mobile applications, which are becoming essential components of comprehensive care strategies. Glucose Monitoring Devices (Dominant) vs. Diabetes Management Software (Emerging) Glucose Monitoring Devices have established themselves as the dominant segment within the US digital diabetes-management market, primarily due to their vital role in enabling real-time blood sugar monitoring for patients. These devices consist of continuous glucose monitors (CGMs) and traditional fingerstick meters, offering varied functionalities to suit different lifestyle preferences and needs. On the other hand, Diabetes Management Software has emerged as a crucial tool for comprehensive diabetes care, leveraging data analytics and patient management features to enhance treatment outcomes. These software solutions are increasingly popular among healthcare providers and patients for their ability to track and analyze health metrics, providing tailored insights and prompting timely interventions. As these technologies evolve, they present opportunities for improved patient engagement and better health management. ### By Product Type: Continuous Glucose Monitors (Largest) vs. Smart Insulin Pens (Fastest-Growing) In the US digital diabetes-management market, Continuous Glucose Monitors hold the largest share, driven by their ability to provide real-time glucose monitoring with minimal need for finger pricks. They are favored for their convenience and long-term health benefits, appealing to a broad range of diabetes patients. Smart Insulin Pens also show significant traction, gaining a notable market share as they offer precision and ease of insulin administration, which is changing the management landscape for Type 1 and Type 2 diabetes patients. The growth of this segment is propelled by technological advancements and an increasing awareness of diabetes management options. As consumers become more health-conscious and seek to leverage technology for better health outcomes, both Continuous Glucose Monitors and Smart Insulin Pens are expected to thrive. Additionally, supportive healthcare policies and rising incidences of diabetes contribute to the upward trend, creating a favorable environment for continuous innovation and product launches within the sector. Continuous Glucose Monitors (Dominant) vs. Smart Insulin Pens (Emerging) Continuous Glucose Monitors are characterized by their ability to deliver continuous readings of glucose levels, which empowers users to make informed decisions regarding their insulin and lifestyle. This dominance is supported by robust clinical studies showcasing improved glycemic control. On the other hand, Smart Insulin Pens are emerging as flexible tools that cater to personalized insulin delivery, coupled with digital tracking capabilities that enhance patient engagement. While Continuous Glucose Monitors are preferred for their comprehensive monitoring system, Smart Insulin Pens are carving a niche by integrating with diabetes management apps, thus offering a new dimension in the diabetes care continuum. Together, these products signify a transformation in patient-centric diabetes management. ### By End User: Individuals (Largest) vs. Healthcare Providers (Fastest-Growing) In the US digital diabetes-management market, the distribution of market share among end users showcases that individuals represent the largest segment. They leverage various digital tools for daily management of diabetes, contributing significantly to the market's growth. Healthcare providers, while smaller in comparison, are rapidly adopting digital solutions to enhance patient care, thus positioning themselves as a vital segment in the evolving marketplace. The growth trends indicate that the individual segment continues to expand at a robust pace, driven by increasing awareness and accessibility of technology. Meanwhile, healthcare providers are embracing digital platforms to improve care delivery, making them the fastest-growing segment. The rise in telehealth services and integration of data analytics are propelling this growth, as both individuals and healthcare entities aim for more efficient diabetes management solutions. Individuals: Dominant vs. Healthcare Providers: Emerging Individuals in the US digital diabetes-management market are characterized by their reliance on mobile applications and wearables that enable better self-monitoring and management of their condition. This segment's dominance is driven by a growing population of diabetes patients seeking user-friendly solutions that offer real-time data and personalized feedback. Conversely, healthcare providers represent an emerging segment, focusing on integrating digital diabetes solutions into clinical practice. With the shift towards patient-centered care, healthcare providers are beginning to realize the benefits of incorporating digital tools, which enhance their ability to deliver tailored treatment plans while improving patient engagement and outcomes. ### By Distribution Channel: Online Sales (Largest) vs. Pharmacies (Fastest-Growing) In the US digital diabetes-management market, the distribution of sales across various channels showcases a dynamic landscape. Online sales have emerged as the largest channel, reflecting a shift towards digital solutions and the convenience they offer. Pharmacies, while traditionally a strong channel, are experiencing significant growth due to increasing integration with health technologies and direct-to-consumer models, making them a crucial player in the market. Growth trends indicate a robust increase in online sales driven by consumer preferences for digital management tools and the convenience of purchasing from home. Pharmacies are evolving rapidly, leveraging technology to offer integrated diabetes management solutions and personalized care, thus positioning themselves favorably for future expansion. This competitive landscape suggests a shift in how patients access diabetes management resources, marking a significant trend in the market. Online Sales (Dominant) vs. Pharmacies (Emerging) Online sales in the US digital diabetes-management market have become the dominant channel, characterized by their user-friendly interfaces, broad accessibility, and extensive product offerings tailored for diabetes management. Consumers appreciate the convenience of ordering supplies and receiving educational resources online. On the other hand, pharmacies represent an emerging channel, steadily adapting to the evolving market landscape by incorporating technology into their services. They not only provide essential medications but also engage in patient education and support services, enhancing the overall diabetes management experience. This duality between the dominance of online sales and the emerging role of pharmacies highlights the diverse approaches to diabetes care, where technology and personal touch can coexist to improve health outcomes. ## Competitive Benchmarking The digital diabetes-management market is characterized by a rapidly evolving competitive landscape, driven by technological advancements and increasing demand for personalized healthcare solutions. Key players such as Abbott (US), Medtronic (US), and Dexcom (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Abbott (US) focuses on continuous glucose monitoring (CGM) systems, emphasizing user-friendly interfaces and integration with mobile applications. Medtronic (US) is enhancing its insulin delivery systems, aiming for seamless connectivity with digital health platforms. Dexcom (US) is expanding its CGM offerings, particularly in the realm of data analytics, which appears to be a critical differentiator in the market. The business tactics employed by these companies include localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the context of fluctuating global trade dynamics. The market structure is moderately fragmented, with a mix of established players and emerging startups. This fragmentation allows for diverse product offerings, yet the collective influence of major companies shapes competitive dynamics significantly, as they set benchmarks for innovation and customer engagement. In October 2025, Abbott (US) announced the launch of its latest CGM system, which integrates advanced AI algorithms to provide real-time glucose predictions. This strategic move not only enhances user experience but also positions Abbott as a leader in predictive analytics within diabetes management. The integration of AI is likely to attract tech-savvy consumers who prioritize data-driven health management. In September 2025, Medtronic (US) unveiled a new partnership with a leading telehealth provider to enhance remote patient monitoring capabilities. This collaboration is strategically significant as it aligns with the growing trend of telehealth services, allowing Medtronic to expand its reach and improve patient outcomes through continuous engagement. Such partnerships may redefine how diabetes care is delivered, emphasizing convenience and accessibility. In August 2025, Dexcom (US) expanded its data-sharing capabilities by integrating with popular health apps, thereby enhancing user engagement and fostering a community of support among diabetes patients. This strategic action reflects a broader trend towards interoperability in health technology, which is essential for creating a holistic diabetes management ecosystem. By facilitating data exchange, Dexcom strengthens its position as a pivotal player in the digital health landscape. As of November 2025, current competitive trends in the digital diabetes-management market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based strategies to a focus on technological innovation, enhanced user experiences, and reliable supply chains. This shift underscores the importance of adaptability and forward-thinking in maintaining a competitive edge in a dynamic market. ## Recent News & Developments In recent months, the US Digital Diabetes Management Market has witnessed notable advancements and developments. Companies such as Glooko, Dexcom, and Omada Health continue to innovate in digital health solutions, focusing on enhancing user engagement and diabetes management outcomes. Medtronic has been expanding its integrated diabetes management systems, improving patient accessibility and connectivity. Notably, in September 2023, Abbott Laboratories announced the launch of a new smart glucose monitoring device aimed at enhancing user experience and data sharing globally. Additionally, in August 2023, Livongo Health and WellDoc teamed up to enhance digital behavioral strategies for chronic condition management, signaling a strategic collaboration to broaden their service offerings. Furthermore, the market shows consistent growth trajectories, with companies such as Bigfoot Biomedical reporting significant increases in market valuations. This growth reflects a heightened demand for technology-driven diabetes solutions amid rising diabetes prevalence in the United States. Recent events within the past two years also include collaborations between Novo Nordisk and MySugr aimed at integrating data into personalized treatment plans, reflecting the sector's combined efforts toward improving patient outcomes through digital transformation in chronic disease management. ## Report Scope | MARKET SIZE 2024 | 950.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1069.51(USD Million) | | MARKET SIZE 2035 | 3499.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.58% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Abbott (US), Medtronic (US), Roche (CH), Dexcom (US), Ascensia Diabetes Care (DE), Insulet Corporation (US), Tandem Diabetes Care (US), Glooko (US) | | Segments Covered | Technology, Product Type, End User, Distribution Channel | | Key Market Opportunities | Integration of artificial intelligence in digital diabetes-management market enhances personalized patient care and treatment outcomes. | | Key Market Dynamics | Rising consumer demand for personalized digital solutions drives innovation in diabetes management technologies. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US digital diabetes-management market in 2024?** A: The market valuation was $950.0 Million in 2024. **Q: What is the projected market valuation for the US digital diabetes-management market by 2035?** A: The projected valuation for 2035 is $3499.0 Million. **Q: What is the expected CAGR for the US digital diabetes-management market during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 12.58%. **Q: Which companies are considered key players in the US digital diabetes-management market?** A: Key players include Abbott, Medtronic, Roche, Dexcom, Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care, and Glooko. **Q: What were the revenue ranges for glucose monitoring devices in the US digital diabetes-management market?** A: Revenue for glucose monitoring devices ranged from $300.0 Million to $1100.0 Million. **Q: How much revenue is projected for diabetes management software by 2035?** A: The revenue for diabetes management software is projected to range from $200.0 Million to $800.0 Million. **Q: What is the revenue range for continuous glucose monitors in the market?** A: The revenue range for continuous glucose monitors is from $300.0 Million to $1200.0 Million. **Q: What segment had the highest revenue in the US digital diabetes-management market in 2024?** A: In 2024, the segment with the highest revenue was glucose monitoring devices. **Q: What is the projected revenue range for online sales in the US digital diabetes-management market by 2035?** A: The projected revenue range for online sales is from $190.0 Million to $700.0 Million. **Q: Which end user segment is expected to generate the most revenue in the US digital diabetes-management market?** A: The individuals segment is expected to generate the most revenue, ranging from $380.0 Million to $1395.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-digital-diabetes-management-market-19625*